Agios Pharmaceuticals (AGIO) Interest Coverage Ratio (2012 - 2026)
Agios Pharmaceuticals (AGIO) posted Interest Coverage Ratio of 2.92 for Q1 2026, up 88.2% on a QoQ basis from 24.72 in Q4 2025, and up 86.77% year-over-year from 1.56 in Q1 2025.
Agios Pharmaceuticals (AGIO) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 2.92 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 86.77% year-over-year to 2.92 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.6 (up 45.93% YoY) and the FY2025 annual result came in at 1.29, up 16.41% from the prior year.
- Interest Coverage Ratio was 2.92 for Q1 2026 at Agios Pharmaceuticals, up from 24.72 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 2.45 in Q3 2025 and bottomed at 26.79 in Q1 2022.
- A 5-year average of 20.42 and a median of 22.12 in 2022 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 88.83% in 2025, while the deepest fall reached 14.37% in 2025.
- Agios Pharmaceuticals' Interest Coverage Ratio stood at 22.41 in 2022, then slipped by 4.08% to 23.33 in 2023, then decreased by 14.29% to 26.66 in 2024, then advanced by 7.29% to 24.72 in 2025, then surged by 88.2% to 2.92 in 2026.
- Business Quant data shows AGIO's Interest Coverage Ratio at 2.92 in Q1 2026, 24.72 in Q4 2025, and 2.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -2.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.92 |
| Dec 31, 2025 | -24.72 |
| Sep 30, 2025 | -2.45 |
| Jun 30, 2025 | -25.87 |
| Mar 31, 2025 | -22.04 |
| Dec 31, 2024 | -26.66 |
| Sep 30, 2024 | -21.95 |
| Jun 30, 2024 | -22.62 |
| Mar 31, 2024 | -19.79 |
| Dec 31, 2023 | -23.33 |
| Sep 30, 2023 | -22.18 |
| Jun 30, 2023 | -20.62 |
| Mar 31, 2023 | -20.05 |
| Dec 31, 2022 | -22.41 |
| Sep 30, 2022 | -20.61 |
| Jun 30, 2022 | -22.12 |
| Mar 31, 2022 | -26.79 |
| Dec 31, 2021 | -28.81 |
| Sep 30, 2021 | -25.22 |
| Jun 30, 2021 | -25.34 |